NCT05942248 The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
| NCT ID | NCT05942248 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Integrative Skin Science and Research |
| Condition | Acne |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2023-06-06 |
| Primary Completion | 2025-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2023-06-06 with a primary completion date of 2025-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study is conducted to determine if image-based computer grading can of acne, melasma, rosacea and seborrheic dermatitis correlate well to expert based clinical severity grading.
Eligibility Criteria
Inclusion Criteria: * Adults with acne, rosacea, melasma or seborrheic dermatitis Exclusion Criteria: * Prisoners * Adults unable to consent * Artificial facial markings on day of facial photography (such as piercings and tattoos) that may interfere with imaging in the opinion of the investigator
Contact & Investigator
Raja Sivamani, MD, MS, AP
PRINCIPAL INVESTIGATOR
Integrative Skin and Research
Frequently Asked Questions
Who can join the NCT05942248 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acne. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05942248 currently recruiting?
Yes, NCT05942248 is actively recruiting participants. Contact the research team at research@integrativeskinresearch.com for enrollment information.
Where is the NCT05942248 trial being conducted?
This trial is being conducted at Sacramento, United States.
Who is sponsoring the NCT05942248 clinical trial?
NCT05942248 is sponsored by Integrative Skin Science and Research. The principal investigator is Raja Sivamani, MD, MS, AP at Integrative Skin and Research. The trial plans to enroll 150 participants.